XML 38 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shared-Based Compensation
3 Months Ended
Mar. 31, 2013
Shared-Based Compensation [Abstract]  
Shared-Based Compensation

Note 10. Shared-Based Compensation

During the three month periods ended March 31, 2013 and 2012, approximately $430 and $358, respectively, of compensation expense was recognized in selling, general and administrative expense for all share-based awards. During the three month periods ended March 31, 2013 and 2012, there were 65 share awards and 254 options awards and 75 share awards and 278 option awards, respectively, granted to non-executive directors, officers and certain other key employees.

The restricted shares granted during the three month periods ended March 31, 2013 and 2012, vest pro-rata over three years. During the three month periods ended March 31, 2013 and 2012, we incurred $163 and $149, respectively, in expense related to restricted stock. The fair value of the shares issued was determined by using the grant date closing price of our common stock.

We incurred $267 and $209 of stock option expense in the three month periods ended March 31, 2013 and 2012, respectively. The fair value of our options cannot be determined by market value, as our options are not traded in an open market. Accordingly, the Black Scholes financial pricing model is utilized to estimate the fair value.

 

The following table provides a reconciliation of option activity for the three month period ended March 31, 2013:

 

                                 

Options

  Shares
(000)
    Weighted-
Average
Exercise
Price
    Weighted-
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value
($000)
 

Outstanding at January 1, 2013

    1,384     $ 9.94                  

Granted

    254     $ 9.97                  

Exercised

    —       $ —                    

Forfeited or expired

    (9   $ 9.36                  
   

 

 

                         

Outstanding at March 31, 2013

    1,629     $ 9.95       6.1     $ 1,732 (1)  
   

 

 

   

 

 

   

 

 

   

 

 

 

Exercisable at March 31, 2013

    1,071     $ 9.69       4.4     $ 1,617 (1)  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

The intrinsic value is the amount by which the market price of our stock was greater than the exercise price of any individual option grant at March 31, 2013.